Brain Scientific Stock Analysis
| BRSF Stock | USD 0.75 0.00 0.00% |
Brain Scientific is overvalued with Real Value of 0.72 and Hype Value of 0.75. The main objective of Brain Scientific pink sheet analysis is to determine its intrinsic value, which is an estimate of what Brain Scientific is worth, separate from its market price. There are two main types of Brain Scientific's stock analysis: fundamental analysis and technical analysis.
The Brain Scientific pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Brain Scientific's ongoing operational relationships across important fundamental and technical indicators.
Brain |
Brain Pink Sheet Analysis Notes
About 24.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.3. Brain Scientific had not issued any dividends in recent years. The entity had 1:85 split on the 3rd of February 2023. Brain Scientific Inc., a medtech company, provides neurology-focused medical devices and electric motors in the United States. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida. Brain Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 28 people.The quote for Brain Scientific is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Brain Scientific please contact Hassan Kotob at 917-388-1578 or go to https://www.brainscientific.com.Brain Scientific Investment Alerts
| Brain Scientific is way too risky over 90 days horizon | |
| Brain Scientific has some characteristics of a very speculative penny stock | |
| Brain Scientific appears to be risky and price may revert if volatility continues | |
| Brain Scientific currently holds 9.97 M in liabilities with Debt to Equity (D/E) ratio of 0.18, which may suggest the company is not taking enough advantage from borrowing. Brain Scientific has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Brain Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Brain Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brain Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brain to invest in growth at high rates of return. When we think about Brain Scientific's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 265.75 K. Net Loss for the year was (9.1 M) with profit before overhead, payroll, taxes, and interest of 83.23 K. | |
| Brain Scientific currently holds about 3.54 M in cash with (5.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 24.0% of Brain Scientific shares are held by company insiders |
Brain Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 316.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Brain Scientific's market, we take the total number of its shares issued and multiply it by Brain Scientific's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 24th of July, Brain Scientific shows the mean deviation of 2.61, and Risk Adjusted Performance of 0.0538. Brain Scientific technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Brain Scientific risk adjusted performance, standard deviation, as well as the relationship between the Standard Deviation and maximum drawdown to decide if Brain Scientific is priced correctly, providing market reflects its regular price of 0.75 per share. As Brain Scientific is a penny stock we also strongly suggest to validate its information ratio numbers.Brain Scientific Price Movement Analysis
The output start index for this execution was fourty-six with a total number of output elements of fifteen. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Brain Scientific middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Brain Scientific. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Brain Scientific Outstanding Bonds
Brain Scientific issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Brain Scientific uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Brain bonds can be classified according to their maturity, which is the date when Brain Scientific has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Brain Scientific Predictive Daily Indicators
Brain Scientific intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Brain Scientific pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Brain Scientific Forecast Models
Brain Scientific's time-series forecasting models are one of many Brain Scientific's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Brain Scientific's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Brain Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Brain Scientific prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Brain shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Brain Scientific. By using and applying Brain Pink Sheet analysis, traders can create a robust methodology for identifying Brain entry and exit points for their positions.
Brain Scientific Inc., a medtech company, provides neurology-focused medical devices and electric motors in the United States. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida. Brain Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 28 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Brain Scientific to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Complementary Tools for Brain Pink Sheet analysis
When running Brain Scientific's price analysis, check to measure Brain Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brain Scientific is operating at the current time. Most of Brain Scientific's value examination focuses on studying past and present price action to predict the probability of Brain Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brain Scientific's price. Additionally, you may evaluate how the addition of Brain Scientific to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |